NanoString Q3 Revenues Jump 27 Percent | GenomeWeb

This story has been updated to include statements from NanoString officials and stock market information.

NEW YORK (GenomeWeb) - NanoString Technologies today reported a 27 percent increase year over year in its third quarter revenues.

For the three months ended Sept. 30, NanoString's total revenues increased to $15.7 million from $12.3 million in the prior-year period, beating the average Wall Street estimate of $15.4 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.